Stroke Gait Rehabilitation Using Functional Electrical Stimulation
17. Februar 2021 aktualisiert von: Trisha Kesar, PT, PhD, Emory University
Cortical and Spinal Correlates of Post-stroke Gait Rehabilitation
The study is a prospective interventional study to assess the changes in corticospinal excitability and spinal reflex excitability of in response to rehabilitative strategies and protocols that are commonly used during physical therapy treatment of gait disorders among post-stroke subjects.
As part of this protocol, 55 individuals with chronic stroke will be assigned to either Cohort 1 or Cohort 2, and will participate in 1-18 gait training sessions.
If interested, study participants can also complete both study cohorts sequentially (with at least 3-weeks duration between switching from one cohort to the second).
The study examines the effects among two cohorts of post stroke patients.
Cohort 1 will participate in 18 sessions of fast treadmill walking plus Functional Electrical Stimulation (FastFES) and Cohort 2 will participate in 1-3 sessions of FastFES and fast walking without FES.
Studienübersicht
Status
Abgeschlossen
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
Stroke is the number one cause of disability. Difficulty with walking affects most stroke survivors. Walking deficits (e.g. reduced ankle flexion during swing phase, decreased forward propulsion during terminal stance) can cause risks of falls, slow walking speed, increased effort of walking, and difficulties with activities of daily living. Restoration of walking ability can improve quality of life, and is perceived as a major goal of rehabilitation by stroke survivors. Examples of interventions that are used to rehabilitate walking post-stroke are functional electrical stimulation, fast treadmill walking, and bio- feedback. While recent research has focused on comparing the effectiveness of different gait rehabilitation interventions, the neural and biomechanical mechanisms underlying different gait rehabilitation strategies are unknown. FastFES is a novel gait training intervention that combines the beneficial effects of two independent interventions: Fast treadmill walking and FES. The FastFES intervention incorporates principles of physiology, biomechanics, motor control and learning, and predictions of forward-dynamic gait simulations to improve post-stroke gait.
The overall purpose of this protocol is to assess the biomechanical and neurophysiologic effects of rehabilitative strategies and protocols that are commonly used during physical therapy treatment of gait disorders post-stroke among two cohorts of people. Aim 1 of the study will assess the changes in gait biomechanics, corticospinal excitability, and walking function during 18 sessions of gait retraining, with participants in Cohort 1. Aim 2 of the study assesses the effect of parameters such as walking speed (slow, fast, variable, split-belt walking), functional electrical stimulation parameters (short-term changes induced by fast versus FastFES, stimulation intensity, number of muscles stimulated), and bio-feedback on within-session changes in gait biomechanics, walking function, and corticospinal excitability, among participants in Cohort 2.
Within Cohort 1, participants will receive identical treatment throughout the 18 training sessions (i.e. FastFES training). Within Cohort 2, participants will participate in 3 training sessions of both FastFES and fast walking training, with a 3-week break between the two types of training.
Studientyp
Interventionell
Einschreibung (Tatsächlich)
24
Phase
- Unzutreffend
Kontakte und Standorte
Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.
Studienorte
-
-
Georgia
-
Atlanta, Georgia, Vereinigte Staaten, 30322
- Emory University
-
-
Teilnahmekriterien
Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.
Zulassungskriterien
Studienberechtigtes Alter
30 Jahre bis 80 Jahre (Erwachsene, Älterer Erwachsener)
Akzeptiert gesunde Freiwillige
Nein
Studienberechtigte Geschlechter
Alle
Beschreibung
Inclusion Criteria:
- Chronic stroke (>6 months post stroke)
- First (single) lesion
- Able to walk with or without the use of a cane or walker
- Sufficient cardiovascular health and ankle stability to walk for 6 minutes at a self-selected speed without an orthoses
- Resting heart rate 40-100 beats per minute
- Resting blood pressure between 90/60-70/90
Exclusion Criteria:
- Evidence of moderate/ severe chronic white matter disease or cerebellar stroke on MRI
- Cerebellar signs (ataxic ("drunken") gait or decreased coordination during rapid alternating hand or foot movements
- Insulin dependent diabetes
- History of lower extremity joint replacement
- Score of >1 on question 1b and >0 on question 1c on NIH Stroke Scale
- Inability to communicate with investigators
- Neglect/hemianopia, or unexplained dizziness in last 6 months
- Neurologic conditions other than stroke
- Orthopedic problems in the lower limbs or spine (or other medical conditions) that limit walking
- Contraindications to transcranial magnetic stimulation (TMS) are: history of seizures, metal implants in the head or face, history of recurring or severe headaches/migraine, headache within the past 24 hours, presence of skull abnormalities or fractures, hemorrhagic stroke, history of dizziness, syncope, nausea, or loss of consciousness in the past 12 months
Studienplan
Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Sonstiges
- Zuteilung: Nicht randomisiert
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: Cohort 1 - FastFES Training
Participants with chronic stroke in Cohort 1 will receive 18 training sessions of FastFES (fast treadmill walking with electrical stimulation).
|
Functional electrical stimulation (FES) is a technique that causes a muscle to contract through the use of an electrical current.
The therapist applies an electrical current to either the skin over the nerve, or over the bulk of the muscle, and this will cause a muscle contraction.
The FES is delivered to 2 muscle groups (dorsiflexor and plantarflexor) timed appropriately with the gait cycle.
FastFES gait training sessions may comprise up to six 6-minute bouts of walking with rest breaks between bouts (total 30-minutes of walking).
The last training bout (bout 6) may comprise 6-minutes of over ground walking, during which subjects will be asked to walk as fast as they can.
For safety, a physical therapist will walk with and guard the subject during over ground walking.
Andere Namen:
|
|
Experimental: Cohort 2 - FastFES and Fast Walking
Participants with chronic stroke in Cohort 2 who complete 3 sessions of FastFES and 3 sessions of fast walking.
|
Functional electrical stimulation (FES) is a technique that causes a muscle to contract through the use of an electrical current.
The therapist applies an electrical current to either the skin over the nerve, or over the bulk of the muscle, and this will cause a muscle contraction.
The FES is delivered to 2 muscle groups (dorsiflexor and plantarflexor) timed appropriately with the gait cycle.
FastFES gait training sessions may comprise up to six 6-minute bouts of walking with rest breaks between bouts (total 30-minutes of walking).
The last training bout (bout 6) may comprise 6-minutes of over ground walking, during which subjects will be asked to walk as fast as they can.
For safety, a physical therapist will walk with and guard the subject during over ground walking.
Andere Namen:
Fast walking training sessions will be similar to FastFES in duration, dosage, structure but no FES will be provided.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Change in Motor Evoked Potentials (MEP) Amplitude Measure in milliVolt (mV) of FastFES Versus Fast Walking After 3 Training Sessions in Cohort 2
Zeitfenster: Baseline, week 3 (after 3 sessions of one intervention), week 6 (after 3 sessions of the other intervention)
|
Change from baseline in MEP amplitude (transverse abdominal (TA) muscle) is used as a measure of corticospinal excitability that is assessed using a non-invasive technique called transcranial magnetic stimulation (TMS).
Electrical activity from muscles in response to the TMS will be collected using surface electromyography (EMG) sensors attached to muscles that play critical roles during FastFES versus Fast walking.
TMS will be delivered using two Magstim 200 stimulators connected via a BiStim module.
An average of 10 TMS-evoked MEP responses will be used to comparing mean peak-to-peak MEP amplitudes in response to suprathreshold TMS delivered to the hotspot.
|
Baseline, week 3 (after 3 sessions of one intervention), week 6 (after 3 sessions of the other intervention)
|
|
Change in H-Reflex /M-Wave (Hmax/Mmax) Ratio Among FastFES Versus Fast Walking After 3 Training Sessions in Cohort 2
Zeitfenster: Baseline, week 3 (after 3 sessions of one intervention), week 6 (after 3 sessions of the other intervention)
|
Change from baseline in (Hmax/Mmax) ratio is used as a measure of spinal reflex excitability, that is assessed using peripheral electrical stimulation delivered to the nerves innervating the ankle muscles.
An electrical stimulation electrode is placed just above the knee, and used as the anode for tibial nerve stimulation.
Electrical stimulation is delivered via surface electrodes in a static position to the popliteal fossa.
The subject's EMG activity will be recorded while the cathode is moved at the back of the knee to determine the location that provides the best EMG response (H-reflex).
EMG activity will be recorded while 50-60 electrical stimuli (short 1 ms square pulses, ranging in intensity in milliAmpere(mA) 1-80), 7-10 seconds apart, are delivered to the muscle.
Also 5-20 electrical stimulus pulses at intensities are delivered that elicit a percentage of the maximum reflex response.
|
Baseline, week 3 (after 3 sessions of one intervention), week 6 (after 3 sessions of the other intervention)
|
|
Change in Motor Evoked Potentials (MEP) Amplitude Measure in milliVolt (mV) of FastFES After 18 Training Sessions in Cohort 1
Zeitfenster: Baseline and up to 6 weeks
|
Change from baseline in MEP amplitude (TA muscle in a resting state) is used as a measure of corticospinal excitability that is assessed using a non-invasive technique called transcranial magnetic stimulation (TMS).
Electrical activity from muscles in response to the TMS will be collected using surface electromyography (EMG) sensors attached to muscles that play critical roles during FastFES versus Fast walking.
TMS will be delivered using two Magstim 200 stimulators connected via a BiStim module.
An average of 10 TMS-evoked MEP responses will be used to comparing mean peak-to-peak MEP amplitudes in response to suprathreshold TMS delivered to the hotspot.
|
Baseline and up to 6 weeks
|
|
Change in H-Reflex /M-Wave (Hmax/Mmax) Ratio Among FastFES Versus Fast Walking After 18 Training Sessions in Cohort 1
Zeitfenster: Baseline and up to 6 weeks
|
Change from baseline in (Hmax/Mmax) ratio is used as a measure of spinal reflex excitability, that is assessed using peripheral electrical stimulation delivered to the nerves innervating the ankle muscles.
An electrical stimulation electrode is placed just above the knee, and used as the anode for tibial nerve stimulation.
Electrical stimulation is delivered via surface electrodes in a static position to the popliteal fossa.
The subject's EMG activity will be recorded while the cathode is moved at the back of the knee to determine the location that provides the best EMG response (H-reflex).
EMG activity will be recorded while 50-60 electrical stimuli (short 1 ms square pulses, ranging in intensity in milliAmpere(mA) 1-80), 7-10 seconds apart, are delivered to the muscle.
Also 5-20 electrical stimulus pulses at intensities are delivered that elicit a percentage of the maximum reflex response.
|
Baseline and up to 6 weeks
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Change in Peak Anterior Ground Reaction Force (AGRF) of FastFES Versus Fast Walking After 3 Training Sessions in Cohort 2
Zeitfenster: Baseline, week 3 (after 3 sessions of one intervention), week 6 (after 3 sessions of the other intervention)
|
Change from baseline in peak AGRF during treadmill walking will be collected using a treadmill instrumented with two force platforms under each belt.
Motion analysis data will be collected during 15- to 40-second long dynamic walking trials as subjects walk on a treadmill.
|
Baseline, week 3 (after 3 sessions of one intervention), week 6 (after 3 sessions of the other intervention)
|
|
Change in Peak Anterior Ground Reaction Force (AGRF) of FastFES Versus Fast Walking After 18 Training Sessions in Cohort 1
Zeitfenster: Baseline and up to 6 weeks
|
Change from baseline in peak AGRF during treadmill walking will be collected using a treadmill instrumented with two force platforms under each belt.
Motion analysis data will be collected during 15- to 40-second long dynamic walking trials as subjects walk on a treadmill.
|
Baseline and up to 6 weeks
|
Mitarbeiter und Ermittler
Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.
Sponsor
Mitarbeiter
Ermittler
- Hauptermittler: Trisha Kesar, PT, PhD, Emory University
Publikationen und hilfreiche Links
Die Bereitstellung dieser Publikationen erfolgt freiwillig durch die für die Eingabe von Informationen über die Studie verantwortliche Person. Diese können sich auf alles beziehen, was mit dem Studium zu tun hat.
Studienaufzeichnungsdaten
Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.
Haupttermine studieren
Studienbeginn (Tatsächlich)
1. August 2013
Primärer Abschluss (Tatsächlich)
1. Mai 2019
Studienabschluss (Tatsächlich)
1. Mai 2019
Studienanmeldedaten
Zuerst eingereicht
15. August 2012
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
16. August 2012
Zuerst gepostet (Schätzen)
20. August 2012
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
10. März 2021
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
17. Februar 2021
Zuletzt verifiziert
1. Februar 2021
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- IRB00058363
- 5K01HD079584-02 (US NIH Stipendium/Vertrag)
- 13SDG13320000 (Andere Kennung: American Heart Association)
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
NEIN
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Nein
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Ja
Produkt, das in den USA hergestellt und aus den USA exportiert wird
Ja
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .